← back to search

Jeffrey M. Karp

Massachusetts Institute of Technology · US
Area of research
Biomedical Engineering · Surgery
Research interest
Research interests include Medicine, Biology, Stem cell, Cell biology, Mesenchymal stem cell, and Organoid.
h-index
citations
11,537
works
39
NIH funding
primary concept
email

Recent publications

A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints
Proceedings of the National Academy of Sciences 2025cited by 11position: middledoi
Gene therapy for CNS disorders: modalities, delivery and translational challenges
Nature reviews. Neuroscience 2024cited by 86position: middledoi
Identification and Management of Ankyloglossia and Its Effect on Breastfeeding in Infants: Clinical Report
PEDIATRICS 2024cited by 29position: middledoi
Encapsulated islet transplantation
Nature Reviews Bioengineering 2024cited by 26position: middledoi
A Pressure‐Sensitive, Repositionable Bioadhesive for Instant, Atraumatic Surgical Application on Internal Organs
Advanced Materials 2024cited by 18position: middledoi
The Future of Drug Delivery
Chemistry of Materials 2023cited by 235position: middledoi
Robust differentiation of human enteroendocrine cells from intestinal stem cells
Nature Communications 2022cited by 69position: middledoi
Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation
Nature Biomedical Engineering 2022cited by 56position: middledoi
BBB pathophysiology–independent delivery of siRNA in traumatic brain injury
Science Advances 2021cited by 152position: middledoi
A therapeutic convection–enhanced macroencapsulation device for enhancing β cell viability and insulin secretion
Proceedings of the National Academy of Sciences 2021cited by 56position: lastdoi
Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study
Otology & Neurotology 2021cited by 51position: middledoi
Shattering barriers toward clinically meaningful MSC therapies
Science Advances 2020cited by 696position: lastdoi
Overcoming the translational barriers of tissue adhesives
Nature Reviews Materials 2020cited by 425position: middledoi
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer
Stem Cells Translational Medicine 2019cited by 122position: middledoi
Progress and challenges towards targeted delivery of cancer therapeutics
Nature Communications 2018cited by 2,124position: middledoi
Towards an arthritis flare-responsive drug delivery system
Nature Communications 2018cited by 247position: lastdoi
Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types
BMC Biology 2018cited by 53position: lastdoi
Clonal Expansion of Lgr5-Positive Cells from Mammalian Cochlea and High-Purity Generation of Sensory Hair Cells
Cell Reports 2017cited by 206position: middledoi
Oral and Dental Aspects of Child Abuse and Neglect
PEDIATRICS 2017cited by 200position: middledoi
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Cancer Discovery 2017cited by 148position: middledoi
Multiscale technologies for treatment of ischemic cardiomyopathy
Nature Nanotechnology 2017cited by 143position: middledoi
Towards a defined ECM and small molecule based monolayer culture system for the expansion of mouse and human intestinal stem cells
Biomaterials 2017cited by 48position: lastdoi
Engineering Stem Cell Organoids
Cell stem cell 2016cited by 830position: middledoi
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Science Translational Medicine 2015cited by 438position: lastdoi
Accelerating the Translation of Nanomaterials in Biomedicine
ACS Nano 2015cited by 323position: middledoi
Application of biomaterials to advance induced pluripotent stem cell research and therapy
The EMBO Journal 2015cited by 90position: lastdoi
Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies
Cell stem cell 2015cited by 63position: middledoi
Mesenchymal stem cells: immune evasive, not immune privileged
Nature Biotechnology 2014cited by 1,542position: lastdoi
A Blood-Resistant Surgical Glue for Minimally Invasive Repair of Vessels and Heart Defects
Science Translational Medicine 2014cited by 313position: middledoi
Niche-independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny
Nature Methods 2013cited by 570position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Róbert Langer · Laboratoire d’immunologie intégrative du cancer15 papers (2012–2023)Oren Levy · Massachusetts Institute of Technology7 papers (2012–2020)Nitin Joshi · Massachusetts Institute of Technology6 papers (2017–2024)Eoin D. O’Cearbhaill · Massachusetts Institute of Technology5 papers (2012–2024)Yuhan Lee · Massachusetts Institute of Technology4 papers (2014–2024) · 3 papers (2012–2014)Sophie S. Liu · Harvard Stem Cell Institute3 papers (2020–2024)Praveen Kumar Vemula · Massachusetts Institute of Technology3 papers (2013–2018)Benjamin E. Mead · Massachusetts Institute of Technology3 papers (2016–2022)Rohit Karnik · Massachusetts Institute of Technology3 papers (2012–2012)James A. Ankrum · Massachusetts Institute of Technology3 papers (2012–2014)Nora Lang · Technical University of Munich3 papers (2012–2014)José Ordovás-Montañés · Broad Institute3 papers (2018–2022)Maria Pereira · Harvard Stem Cell Institute3 papers (2012–2020)Pedro J. del Nido · Boston Children's Hospital3 papers (2012–2014)Kisuk Yang · Massachusetts Institute of Technology3 papers (2020–2024)Seung Yun Yang · Massachusetts Institute of Technology2 papers (2012–2013)Ben Mead · University of Birmingham2 papers (2015–2017)Allison E. Hamilos · Massachusetts Institute of Technology2 papers (2015–2021)Steve Wasserman · Massachusetts Institute of Technology2 papers (2012–2014)